Lifecore Biomedical Inc. (LFCR) - Total Liabilities
Based on the latest financial reports, Lifecore Biomedical Inc. (LFCR) has total liabilities worth $213.41 Million USD as of May 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Lifecore Biomedical Inc.'s assets are long-term investments to see how much of total assets are deployed in long-term investments.
Lifecore Biomedical Inc. - Total Liabilities Trend (1996–2026)
This chart illustrates how Lifecore Biomedical Inc.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see LFCR total assets.
Lifecore Biomedical Inc. Competitors by Total Liabilities
The table below lists competitors of Lifecore Biomedical Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Scottie Resources Corp
V:SCOT
|
Canada | CA$2.13 Million |
|
1911 Gold Corp
V:AUMB
|
Canada | CA$9.87 Million |
|
Sparebanken Ost
OL:SPOG
|
Norway | Nkr40.78 Billion |
|
Daeho Al Co. Ltd.
KO:069460
|
Korea | ₩66.52 Billion |
|
Sang-A Frontec Co.Ltd
KQ:089980
|
Korea | ₩188.59 Billion |
|
Valens
NYSE:VLN
|
USA | $27.86 Million |
|
Jyong Biotech Ltd. Ordinary Shares
NASDAQ:MENS
|
USA | $45.68 Million |
|
Tianjin Capital Environmental Protection Group Company Limited
F:TIA
|
Germany | €14.34 Billion |
Liability Composition Analysis (1996–2026)
This chart breaks down Lifecore Biomedical Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Lifecore Biomedical Inc. to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 13.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.93 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lifecore Biomedical Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lifecore Biomedical Inc. (1996–2026)
The table below shows the annual total liabilities of Lifecore Biomedical Inc. from 1996 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-05-31 | $246.38 Million | +3.52% |
| 2025-05-31 | $238.01 Million | -1.91% |
| 2024-05-31 | $242.65 Million | +29.84% |
| 2023-05-31 | $186.88 Million | -0.18% |
| 2022-05-31 | $187.22 Million | -37.62% |
| 2021-05-31 | $300.14 Million | -3.26% |
| 2020-05-31 | $310.27 Million | +24.63% |
| 2019-05-31 | $248.95 Million | +63.63% |
| 2018-05-31 | $152.14 Million | +17.16% |
| 2017-05-31 | $129.86 Million | -0.96% |
| 2016-05-31 | $131.12 Million | +3.77% |
| 2015-05-31 | $126.36 Million | +16.07% |
| 2014-05-31 | $108.86 Million | -1.51% |
| 2013-05-31 | $110.53 Million | -12.37% |
| 2012-05-31 | $126.13 Million | +83.91% |
| 2011-05-31 | $68.59 Million | +1.28% |
| 2010-05-31 | $67.72 Million | +163.82% |
| 2009-05-31 | $25.67 Million | -25.75% |
| 2008-05-31 | $34.57 Million | +18.02% |
| 2007-05-31 | $29.30 Million | -9.04% |
| 2006-05-31 | $32.20 Million | +21.30% |
| 2005-05-31 | $26.55 Million | -11.23% |
| 2004-05-31 | $29.91 Million | -20.40% |
| 2003-05-31 | $37.57 Million | -25.25% |
| 2002-05-31 | $50.26 Million | -27.42% |
| 2001-05-31 | $69.25 Million | +3.77% |
| 2000-05-31 | $66.73 Million | +649.82% |
| 1999-05-31 | $8.90 Million | +2.30% |
| 1998-05-31 | $8.70 Million | -40.41% |
| 1997-05-31 | $14.60 Million | +711.11% |
| 1996-05-31 | $1.80 Million | -- |
About Lifecore Biomedical Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device … Read more